Acronyms that contain the term nephrogenic systemic fibrosis 

Nephrogenic systemic fibrosis

Nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy is a rare and serious syndrome that involves fibrosis of skin, joints, eyes, and internal organs. The first cases were identified in 1997 and its cause is not fully understood. However, there is much evidence to suggest that it is associated with exposure to gadolinium in patients with severe kidney failure. Epidemiological studies suggest that the incidence of NSF is unrelated to gender, race, or age and it is not thought to have a genetic basis. A registry for NSF has identified about 335 cases as of 2011. Most patients with NSF have undergone hemodialysis for renal failure, some have never undergone dialysis and others have received only peritoneal dialysis. Many patients have taken immunosuppressive medications and have other diseases, such as hepatitis C. Four of the seven gadolinium contrast agents approved by the U.S. Food and Drug Administration have been principally implicated in NSF, including Omniscan, MultiHance, Magnevist, and OptiMARK.

see more »